Aortic root reoperations after pulmonary autograft implantation  by Bekkers, J.A. et al.
Aortic Symposium 2010 Bekkers et alAortic root reoperations after pulmonary autograft implantationJ. A. Bekkers, MD,a L. M. A. Klieverik, MD, PhD,b G. Bol Raap, MD, PhD,a J. J. M. Takkenberg, MD,
PhD,a and A. J. J. C. Bogers, MD, PhDaFrom th
gy,b E
Disclosu
A. J.
Receive
for pu
Address
Bd 5
CA R
0022-52
Copyrig
doi:10.1
S58Objective: To report the results of aortic root reoperations after pulmonary autograft implantation.
Methods: All consecutive patients in our prospective Ross research database were selected for analysis, and
additional information for patients requiring reoperation was obtained from the hospital records.
Results: From 1988 to 2009, 155 pulmonary autograft operations were performed. During this period, 41 pa-
tients required reoperation for aortic root dilatation and/or autograft valve insufficiency, in 8 patients combined
with pulmonary allograft dysfunction. The freedom from autograft reoperation rate was 86% (standard error,
3.3%) after 10 years and 52% (standard error, 6.6%) after 15 years. The median interval to reoperation was
15.3 years. During reoperation, 39 patients underwent aortic root replacement (mechanical conduit, 31; stentless
root, 2; allograft, 3; and valve sparing, 3), and 2 patients underwent valve replacement. In 8 patients this was
combined with pulmonary allograft replacement. The technical difficulties encountered included bleeding at
the sternal re-entry in 5 patients. No 30-day mortality occurred. The postoperative complications included re-
exploration for persistent blood loss in 3 patients and cerebrovascular accident in 3 patients. Two patients
died during the follow-up period. The survival rate after reoperation was 94% (standard error, 4.1%) at 5 years.
Conclusions: An increasing number of patients requires reoperation after pulmonary autograft implantation.
These reoperations can be done with very lowmortality and morbidity and excellent follow-up results. (J Thorac
Cardiovasc Surg 2010;140:S58-63)Pulmonary autograft implantation (the Ross operation) is an
attractive option for aortic valve replacement, especially in
children and young adults.1 The operativemortality and lon-
ger term results have been very satisfactory. A major draw-
back of this operation, however, is the progressive dilatation
of the autograft root, often combinedwith autograft valve in-
sufficiency, necessitating reoperation. Reoperations after
previous aortic root surgery are complex and carry increased
operative risks.2-5 In particular, reopening the chest, with the
possible adherence of the dilated aorta to the sternum and the
need for mobilization and reimplantation of the coronary
arteries might contribute to the high-risk character of these
reoperations and, therefore, the greater expected mortality
risk in reoperative patients. In our center, a high volume of
pulmonary autograft procedures was performed in the past
2 decades.6 Re-replacement of the aortic root will usually
be performed using implantation of a valved conduit; how-
ever, recently, valve-sparing procedures after previous aortic
root replacement have also been introduced.7
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The Journal of Thoracic and Cardiovascular Surgimplantation and to report our experience with these reoper-
ations.MATERIALS AND METHODS
Patients
From 1988 to 2009, 155 consecutive patients underwent the Ross oper-
ation at our institution. In 149 patients, we performed a full root implanta-
tion; in 6 patients, an inclusion cylinder was implanted. The preoperative
patient characteristics are listed in Table 1. Twelve patients underwent pre-
vious aortic valve replacement: 6 subcoronary homografts, 3 biologic pros-
theses, and 3 mechanical prostheses were used. The institutional review
board approved the present prospective follow-up study and waived the
need for informed consent.
Primary Operation
The perioperative data are listed in Table 2. All surgical procedureswere
performed with cardiopulmonary bypass with moderate hypothermia. In 3
patients, additional deep hypothermia with total circulatory arrest was
needed for surgery on the aortic arch. Crystalloid cardioplegia and topical
cooling were used for myocardial protection.
In most patients, the root replacement technique was used, and the pul-
monary autograft was inserted at the level of the annulus, with care taken to
reduce the subannular muscular rim of the autograft to 3 to 4mm. The prox-
imal suture line of the autograft was constructed, with interrupted sutures in
21% (n ¼ 30) of the procedures and running sutures in the remainder. In 2
patients, an autologous pericardial strip supported the proximal suture line.
In all patients, the right ventricular outflow tract was reconstructed using
an allograft. In 98%, a pulmonary allograft was used, and 99% of the
allografts used were cryopreserved. Three patients required concomitant
coronary artery bypass grafting because of a procedural complication.
The details of these patients have been previously reported.6
Reoperations
All reoperations were performed through a median sternotomy, with
cardiopulmonary bypass and moderate hypothermia. We mostly usedery c December 2010
TABLE 1. Preoperative patient characteristics (n ¼ 155)
Bekkers et al Aortic Symposium 2010Characteristic Value
Age (y)
Mean  SD 21.4  13.7Abbreviations and Acronyms
HR ¼ hazard ratio
CI ¼ confidence intervalRange 0.05–52
Age group (%)
0–16 39 (n ¼ 61)
>16 61 (n ¼ 102)
Male gender 66 (n ¼ 96)
Previous cardiac surgery* 33 (n ¼ 51)
Previous aortic valve replacement 8 (n ¼ 12)
Previous valvulotomy 18 (n ¼ 28)
Previous balloon dilatation 22 (n ¼ 33)
Etiology
Endocarditis 5 (n ¼ 8)
Congenital (including bicuspid) 75 (n ¼ 117)
Other (mainly prosthetic valve) 12 (n ¼ 18)
Degenerative/rheumatic 7 (n ¼ 11)
Aneurysm/dissection 1% (n ¼ 1)
Diagnosis
Aortic valve regurgitation 29 (n ¼ 45)
Aortic valve stenosis 32 (n ¼ 50)
Aortic valve regurgitation plus
aortic valve stenosis
39 (n ¼ 60)
Systolic LVFy (n ¼ 148)
Good 83 (n ¼ 124)
Impaired 12 (n ¼ 16)
Moderate/poor 5 (n ¼ 8)
Sinus rhythm 100
Creatinine (mmol/L) (n ¼ 145)
Mean  SD 62  24
Range 12–157
NYHA class (n ¼ 148)
I 42 (n ¼ 62)
II 36 (n ¼ 54)
III 16 (n ¼ 24)
IV-V 5 (n ¼ 8)
Ventilation support 3 (n ¼ 4)
Operation type
Emergency (<24 h) 1 (n ¼ 2)
Urgent 16 (n ¼ 25)
Elective 83 (n ¼ 128)
LVF, Left ventricular function; NYHA, New York Heart Association. *Some patients
had other previous cardiac surgery (ie, ventricular septal defect closure, subvalvular
membrane resection. ySystolic left ventricular function based on qualitative echocar-
diographic estimations.central cannulation in the ascending aorta and right atrium or caval veins.
To anticipate possible perforation of the heart or aorta when reopening the
chest, we instituted cardiopulmonary bypass with canulation of the femoral
vessels and deep cooling in 4 patients before performing the sternotomy.
Crystalloid cardioplegia and topical cooling were used for myocardial pro-
tection. Total circulatory arrest with deep hypothermia was needed in 11
patients, with ascending aorta or arch reconstruction, necessary to correct
ascending aortic or arch dilatation.
In patients without aortic root dilatation, the valve leaflets were excised,
followed by mechanical valve implantation. The neo-aortic root was in
most cases dilated without any signs of root or valve calcification. After
opening the autograft root, the autograft valve leaflets were inspected,
and most of them were excised and the coronary buttons mobilized. Excess
autograft wall tissue was removed, leaving parts of the autograft at the an-
nular level in situ. Standard valved conduit implantation was performed.
When appropriate, the valve leaflets were spared, using the aortic valve
reimplantation technique.8
Follow-up
All patients were followed up prospectively and annually contacted and
interviewed by telephone. Patients older than 16 years underwent standard-
ized echocardiography biannually.9 In the case of suspected complications,
the attending physician was contacted for verification. Valve-related events
were defined according the 2008 guidelines for reporting morbidity and
mortality after cardiac valvular operations.10 Failure of the autograft or pul-
monary allograft was determined at reoperation or death. The recording of
patient survival was started at the Ross operation and ended at death or the
last follow-up visit. Survival of the autograft or pulmonary allograft was
started at surgery and ended when reoperation or reintervention was neces-
sary, the patient died, or the last follow-up visit. Two patients moved abroad
and were lost to follow-up.
The database was frozen on December 1, 2009. The total follow-up was
1694 patient-years and was 97% complete. The mean follow-up duration
was 11.0 years (range, 0-20.4 years).
Statistical Analysis
Descriptive statistical analysis of the perioperative data was done. Con-
tinuous data are displayed as mean  1 standard deviation. Discrete data
are presented as proportions. Cumulative survival and freedom from reop-
eration or reintervention were analyzed using the Kaplan-Meier method.
Survival is displayed as the proportion  standard error. The log-rank
test was used to compare the Kaplan-Meier curves.
The Cox proportional hazards regression analysis was used to evaluate
the following variables as predictors for autograft reoperation over time:
previous aortic valve replacement, patient age, bicuspid valve disease, sur-
gical technique used (root replacement versus inclusion cylinder tech-
nique), and hemodynamic diagnosis (regurgitation versus stenosis versus
combined regurgitation and stenosis). First, all variables were entered
into a univariate analysis. Next, all variables that were significant on uni-
variate analysis or showed a tendency toward significance (P  .20) were
forced into the multivariate Cox regression analysis (enter method). The
proportional hazards assumption was assessed for each variable through
graphic inspection of the log minus log survival and the linearity assump-
tion for continuous variables though the partial residuals. No indication
was seen of a violation of the assumptions. All testing was performed
2-sided. For all data analysis, the Statistical Package for Social Sciences,
version 15.0.0, for Windows (SPSS, Chicago, Ill) was used.The Journal of Thoracic and CarRESULTS
Early Mortality After Primary Operation
The early mortality rate at 30 days was 2.6% (4 patients).
Two patients, both female, died during surgery. Of these 2
patients, 1, a 40-year-old patient, died of low output failure
and the other patient (4 months old) died of heart failure and
severe arrhythmias. A third patient, a 26-year-old man, died
of massive pulmonary emboli shortly after surgery. Finally,
a 24-year-old female patient with Turner syndrome and ex-
treme left ventricular hypertrophy died of mediastinitis and
sepsis 13 days after surgery.diovascular Surgery c Volume 140, Number 6S S59
TABLE 2. Perioperative details (n ¼ 155)
Variable Patients (%)
Aortic valve
Bicuspid 60 (n ¼ 93)
Tricuspid 32 (n ¼ 49)
Prosthesis 8 (n ¼ 12)
Surgical technique
Autograft root replacement 96 (n ¼ 149)
Inlay autograft 4 (n ¼ 6)
Concomitant procedures
CABG 2 (n ¼ 3)
LVOT enlargement 12 (n ¼ 19)
Mitral valve surgery 1 (n ¼ 2)
Other* 12 (n ¼ 18)
CPB time (min) 201 (114–685)
Crossclamp time (min) 141 (90–240)
Circulatory arrest (min; n ¼ 3) 30 (11–64)
Complications
Bleeding/tamponade 13% (n ¼ 20)
Pacemaker 1% (n ¼ 1)
Perioperative MI 1% (n ¼ 1)
Early mortality 2.6% (n ¼ 4)
CABG, Coronary bypass operation; LVOT, left ventricular outflow tract; CPB, cardio-
pulmonary bypass; MI, myocardial infarction. *Included patients requiring tailoring
of ascending aorta or subvalvular membrane resection.
FIGURE 1. Observed cumulative survival after the Ross operation.
TABLE 3. Reoperation characteristics
Characteristic Patients (n)
Indication for reoperation
Aortic root dilatation with aortic regurgitation 34
Isolated aortic root dilatation 5
Isolated aortic regurgitation 2
Aortic root procedure 41
Aortic root replacement 39
Allograft 3
Valved conduit 31
Stentless root 2
Valve sparing 3
Aortic Symposium 2010 Bekkers et alLate Survival After Primary Operation
During follow-up, 7 more patients died. Of the 7 deaths, 3
were valve-related and 4 were nonvalve-related deaths. One
valve-related death was a 12-year-old girl with severe juve-
nile rheumatic disease and severe aortic valve regurgitation
and mitral valve incompetence, resulting in progressive
heart failure. She died 6 months after surgery of recurrent
rheumatic disease.11 The other 2 valve-related deaths
were both sudden, unexpected, and unexplained deaths.
One adult patient died 13.8 years after autograft implanta-
tion, and one died 10.8 years after autograft implantation
and 1 year after autograft replacement for progressive
neo-aortic dilatation and regurgitation.
The causes of the nonvalve-related deaths included septic
shock (Candida albicans) in 1 infant 51 days after autograft
implantation, heart failure resulting in cardiogenic shock in
another infant 1.7 years after autograft implantation, acute
myocardial infarction in 1 adult patient 4.7 years after auto-
graft implantation and 2 months after autograft replacement
for progressive neo-aortic dilatation and regurgitation, and
heart failure with normal functioning autograft in 1 adult
patient 16.2 years after autograft implantation.
The overall 15-year survival rate was 92%  1.8%
(Figure 1).
Aortic valve implantation 2
Additional procedures
Pulmonary allograft replacement 8
Allograft 7
Valved conduit 1
Mitral valve repair/replacement 4Reoperation
A total of 41 patients underwent reoperation on the au-
tograft, of which 3 were in other institutions. All patients
who required reoperation of the autograft had originallyS60 The Journal of Thoracic and Cardiovascular Surgundergone full root implantation. The mean age was 36
years (range 16-64 years) at reoperation. Of these 41 pa-
tients, 33 required isolated pulmonary autograft reopera-
tion, 8 required simultaneous replacement of both the
pulmonary autograft and the allograft.
Progressive dilatation of the neo-aortic root combined
with aortic regurgitation was the main cause for autograft
reoperation. The causes for allograft replacement were
mainly structural failure, calcification, or senile degenera-
tion of the valve. The details of the reoperative procedures
are listed in Table 3. In 1 patient, an aortic valve replace-
ment was performed 8 years after the primary Ross opera-
tion for neo-aortic regurgitation with a moderately dilated
neo-aorta, followed by mechanical conduit implantation 4
years later for progressive ascending aortic dilatation. The
technical difficulties encountered at these reoperations
were accidental injury of the aorta or pulmonary artery at
reopening the chest in 5 patients, in 3 patients requiring
emergency institution of cardiopulmonary bypass using
the femoral vessels. No reoperative mortality occurred.ery c December 2010
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Time (years since operation)
Freedom from autograft redo Rotterdam Ross patients 
(N=155)
N=84 N=13Number at risk:
Freedom from autograft redo at 10 years: 86% (95% CI 80-92%)
Freedom from autograft redo at 15 years: 52% (95% CI 39-65%)
FIGURE 2. Overall freedom from autograft reoperation.
Bekkers et al Aortic Symposium 2010Postoperative morbidity included rethoracotomy for persis-
tent blood loss in 3 patients (7.3%) and stroke in 3 patients
(7.3%). In 1 patient, the stroke was related to accidental in-
jury of the pulmonary allograft and hypovolemic shock at
reopening of the chest.
Two patients died after these reoperations. One patient
died 3 months postoperatively of a myocardial infarction.
The second patient died 17 months postoperatively; the
death was sudden and unexplained. The freedom from reop-
eration for autograft failure rate at 10 years was 86% 
3.3% and was 52%  6.6% at 15 years (Figure 2). The
rate of freedom from autograft reoperation was comparable
between patients younger than 16 years and those aged 16
years or older at surgery (log-rank test, chi-square 2.288;
P ¼ .13).
The only univariate predictor of autograft reoperation
was preoperative pure aortic regurgitation (hazard ratio
[HR], 1.86; 95% confidence interval [CI], 0.99-3.49; P ¼
.05). Adult patient age showed a tendency toward greater
autograft reoperation rates (HR, 1.73; 95% CI, 0.84-3.56;
P ¼ .14). After multivariate analysis, the adult patient age
was no longer significant (HR, 1.53; 95% CI, 0.72-3.21;
P ¼ .26), and pure aortic regurgitation showed a trend to-
ward greater autograft reoperation rates (HR, 1.70; 95%
CI, 0.89-3.24; P ¼ .11).Other Valve-Related Events
During follow-up, 2 patients developed endocarditis
(0.11%/patient-year), complicated by a stroke in 1 patient.
In 1 patient, allograft endocarditis occurred and was treated
with antibiotics (0.06%/patient-year). One patient devel-
oped pulmonary emboli (0.06%/patient-year). Bleeding
events, valve thrombosis, or nonstructural failure was not
observed.Functional Status at Follow-up
At the last follow-up visit, 95% of the patients were in
New York Heart Association class I or II, and 5% of pa-
tients (n ¼ 6) were in New York Heart Association classThe Journal of Thoracic and CarIII-IVowing to aortic regurgitation or heart failure. Finally,
5% of the patients had moderate to severe aortic regurgita-
tion, 1% had moderate to severe pulmonary regurgitation,
and 7% of the patients had moderate to severe pulmonary
stenosis.
DISCUSSION
Although the Ross operation has provided very satisfac-
tory results in the first postoperative decade, over time an in-
creasing number of patients will require reintervention. Of
our series of 155 primary Ross operations, 41 patients un-
derwent reintervention on the aortic root with a median in-
terval to reintervention of 15.3 years (range, 1.8-18.7
years). Since the completion of the present study, 4 addi-
tional patients were scheduled for reoperation. The freedom
from reoperation rate at 10 years was 86%. These results
are comparable to those of other series.12,13 Most of our
reoperations occurred in the second decade after the Ross
operation. In a meta-analysis of 17 consecutive series of
both children and adults, the yearly rate of structural valve
deterioration or nonstructural valve deterioration for the au-
tograft valve was estimated to be 1.15% (95% CI, 1.06-
2.06%).1 In our series, with a longer follow-up than other
series in the meta-analysis, we found a yearly rate of struc-
tural valve deterioration or nonstructural valve deterioration
of 1.81%, well within the 95% CI of the pooled series.6
Given that in our institution, none of the autograft roots
were implanted in an intra-annular method and no proximal
support was used, technical adaptations of the pulmonary
root implantation might be helpful in preventing, or at least
delaying, these reoperations. Charitos and colleagues14 re-
ported on the results of the German-Dutch Ross Registry.
They found that reinforcement of the proximal suture line
in a full root Ross operation leads to a reduction of the re-
operation rate at 10 years of follow-up.14 In their series,
the mean follow-up duration of only 8 years in the patients
with a reinforced proximal suture line was shorter than in
patients without reinforcement. Conceptually, it is hard to
understand by which mechanism, that the reinforcement
of the proximal suture line only will prevent the sinuses
of Valsalva and distal parts of the pulmonary autograft
root from dilation. Others have advocated reinforcement
of the entire pulmonary root with a prosthetic graft.15,16
These advanced techniques for the Ross operation might
be attractive additions to the operation in an adult patient
population. In growing children, however, some degree of
dilatation or growth of the autograft will be advantageous
to the patient. It is hard to foresee what technical
modifications of the operation would allow for some
degree of diameter augmentation of the implanted root
but would prevent aneurysmal dilatation and subsequent
valve dysfunction.
In the present series, we had no mortality in 41 reopera-
tions. The operative mortality rate after previous ascendingdiovascular Surgery c Volume 140, Number 6S S61
Aortic Symposium 2010 Bekkers et alaortic or aortic valve surgery is reported to be 5.4% to
17.9%.2-5 Most of these series are combined series of
patients with different types of previous aortic root
procedures. The risk factors for mortality are mostly
advanced age and the need for coronary revascularization,
either planned or unforeseen.3-5 In our series of exclusively
reoperations after pulmonary autograft implantation, the
patients were relatively young, and no coronary
revascularization was necessary. In these reoperations, the
coronary buttons are usually relatively easy to prepare,
because, in contrast to reoperations after previous allograft
implantation, aortic wall calcification is absent.
Our experience has shown that the reoperations can be
performed safely with little morbidity and no reoperative
mortality, but with a few surgically challenging technical
difficulties, the consequences of which can be avoided by
paying particular attention to the reopening of the chest. Be-
cause in most patients, the aortic root and ascending aorta
are dilated, these structures can become adherent or very
close to the posterior aspect of the sternum. Preoperative
computed tomography scanning might help identify pa-
tients at risk of aortic injury at reopening the chest. In these
patient, elective femoral vessel canulation will allow safe
entry into the chest. Nevertheless, we encountered acciden-
tal aortic or pulmonary artery injury in 5 patients, requiring
emergency installation of cardiopulmonary bypass with
femoral vessel canulation. From this experience, we rou-
tinely performed computed tomography of the chest in the
preoperative workup of these patients.
Because the most prominent indication for reoperation is
aortic root dilatation, aortic root replacement is required.
Only 2 patients in our series had structural valve dysfunc-
tion without severe aortic dilatation. In these patients, inser-
tion of an aortic valve prosthesis in the pulmonary autograft
root was possible. In 1 of these patients, a moderately di-
lated ascending aorta was untouched at reoperation, but pro-
gressive ascending aortic dilatation necessitated ascending
aortic replacement 4 years later. In patients with aortic
root dilatation without structural aortic valve dysfunction,
a valve-sparing root replacement might be possible. Our
systematic biannual echocardiographic follow-up protocol
helps in identifying asymptomatic patients with significant
aortic root dilatation. These patient can undergo elective re-
operation before the onset of potentially lethal aortic com-
plications, such as aortic dissection. Performing reoperation
before severe aortic insufficiency has developed could en-
hance the possibilities for valve-sparing procedures and
prevent irreversible myocardial damage.
The indication for a Ross operation has been a matter of
debate, and recent reports have shown an increasing inci-
dence of reoperations after pulmonary autograft implanta-
tion.1,6,17 Our results have shown a substantial proportion
of patients requiring reoperation after a Ross operation.
The present report provides information about the risksS62 The Journal of Thoracic and Cardiovascular Surgof these reoperations and might therefore be useful in
determining the preferred choice for a valve substitute in
patients with aortic valve disease. In adults patients, our
initial enthusiasm for the Ross operation has tempered.
We have not performed a Ross operation in an adult
patient in the past 7 years. In children and young adults,
however, the pulmonary autograft might still be the
preferred valve substitute, given the excellent short- and
long-term results and the lack of a reasonable alternative.
The decision for a valve substitute should take into account,
weighing the risks and benefits of the available treatment
strategies, combined with careful elicitation of patient pref-
erences to ascertain patient-tailored optimal treatment
selection.
CONCLUSIONS
In our prospective cohort, reoperation of the autograft
root was observed increasingly in the second decade after
the Ross operation. Careful monitoring of patients over
time and adequate timing of the reoperation and a surgical
strategy tailored to the mode of autograft failure are the ba-
sic requirements for a safe and successful reoperation.
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